PV Bulletin

EMA ETF recommends updating COVID-19 vaccines to target XFG variant for 2026/2027 campaign

The Emergency Task Force of the EMA has recommended that marketing authorisation holders update their COVID-19 vaccines to target the XFG variant for the 2026/2027 vaccination campaign due to decreased efficacy of existing vaccines.

Primary source: European Medicines Agency (EMA)

PV Impact Brief

MonitoringConfidence: high

What changed

ETF recommended that marketing authorisation holders update their COVID-19 vaccines to target the XFG variant for the 2026/2027 vaccination campaign.

Why it matters

Decreased efficacy of existing vaccines against the XFG variant could reduce protection against COVID-19, necessitating vaccine strain updates.

Action needed

Marketing authorisation holders should prepare to update their COVID-19 vaccines to target the XFG variant for the upcoming campaign; monitor for further regulatory guidance and prepare for potential strain change submissions.

Relevant for
Regulatory Intelligence LeadSignal Management Lead
Processes impacted
Signal ManagementLabeling
Owner

Regulatory Intelligence Lead

Review cadence

quarterly

Regulatory action details

Action type
Regulatory Recommendation / Public Health Communication
Publication date
2026-05-29
Last updated
2026-05-29
Safety issue
Decreased efficacy of existing vaccines against the evolving XFG variant of COVID-19.

Affected products

  • COVID-19 vaccines
    Marketing authorisation holders (various)

PV internal implications

Requires monitoring of vaccine efficacy signals and potential preparation for strain change variations.

View regulator source

Evidence and confidence

Confidence: highSource updated: May 29, 2026

Full briefing

Practical implication

Marketing authorisation holders should prepare to update their COVID-19 vaccines to target the XFG variant for the upcoming campaign; monitor for further regulatory guidance and prepare for potential strain change submissions.

The EMA ETF recommends updating COVID-19 vaccines to target the XFG variant for the 2026/2027 campaign, citing decreased efficacy of current vaccines against the evolving variant.

What changed: ETF recommended that marketing authorisation holders update their COVID-19 vaccines to target the XFG variant for the 2026/2027 vaccination campaign.

Why it matters: Decreased efficacy of existing vaccines against the XFG variant could reduce protection against COVID-19, necessitating vaccine strain updates.

Practical implication: Marketing authorisation holders should prepare to update their COVID-19 vaccines to target the XFG variant for the upcoming campaign; monitor for further regulatory guidance and prepare for potential strain change submissions.

View original source

Published from the Firecrawl agent regulatory extraction pipeline.

#Safety Signals#firecrawl-agent#regulatory-extraction#Other#Vaccine Updates#Regulatory Recommendation / Public Health Communication#European Medicines Agency (EMA)

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward